{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:56:34Z","timestamp":1793325394005,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Startup Fund for Scientific Research, Fujian Medical University","award":["2023QH2014"],"award-info":[{"award-number":["2023QH2014"]}]},{"name":"Stomatological Key Laboratory of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University","award":["2022GXA02"],"award-info":[{"award-number":["2022GXA02"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272868"],"award-info":[{"award-number":["82272868"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173180"],"award-info":[{"award-number":["82173180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Special Project of Central Government for Local Science and Technology Development of Fujian Province","award":["2023L3011"],"award-info":[{"award-number":["2023L3011"]}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2024Y9341"],"award-info":[{"award-number":["2024Y9341"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Oral squamous cell carcinoma (OSCC) remains one of the most aggressive malignancies of the oral epithelium, with limited therapeutic options effectively targeting both tumor growth and metastasis. Plant-derived nanovesicles have emerged as natural, biocompatible nanomedicines with potential applications in cancer therapy. Here, we systematically screened nanovesicles from ten medicinal plants and identified\n                    <jats:italic>Panax notoginseng<\/jats:italic>\n                    -derived nanovesicles (PnNVs) as the most potent inhibitors of OSCC. PnNVs exhibited favorable safety profiles and intrinsic tumor-homing ability, selectively accumulating in orthotopic tongue tumors. In vivo, they markedly suppressed primary tumor growth and lymphatic metastasis. Mechanistically, PnNVs disrupted redox homeostasis by inhibiting the p38\u2013MAPK\/NRF2 signaling pathway, thereby inducing ferroptosis, autophagy, and PANoptosis. In addition, PnNVs impaired cancer cell migration by modulating chemokine-associated signaling pathways critical for tumor dissemination. Multi-omic analyses further revealed synergistic contributions of RNA cargos and metabolite components to their multi-target anticancer efficacy. Collectively, our findings establish PnNVs as a natural, multifunctional therapeutic candidate with dual anti-proliferative and anti-metastatic activity, providing a promising preclinical strategy for OSCC treatment.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-026-04193-9","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:03:03Z","timestamp":1772816583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Natural panax notoginseng-derived nanovesicles trigger multiple cell death mechanisms and reprogram chemokine signaling to impede oral squamous cell carcinoma progression"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaohang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzheng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genggeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaochao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youguang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"1","key":"4193_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S, et al. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci. 2023;15(1):44.","journal-title":"Int J Oral Sci"},{"issue":"1","key":"4193_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10565-025-10048-0","volume":"41","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Wang L, Liu M, Jiang H, Wu Y. Oral squamous cell carcinoma: insights into cellular heterogeneity, drug resistance, and evolutionary trajectories. Cell Biol Toxicol. 2025;41(1):101.","journal-title":"Cell Biol Toxicol"},{"issue":"17","key":"4193_CR3","doi-asserted-by":"publisher","first-page":"18153","DOI":"10.1002\/cam4.6391","volume":"12","author":"J Huang","year":"2023","unstructured":"Huang J, Chan SC, Ko S, Lok V, Zhang L, Lin X, et al. Disease burden, risk factors, and trends of lip, oral cavity, pharyngeal cancers: a global analysis. Cancer Med. 2023;12(17):18153\u201364.","journal-title":"Cancer Med"},{"key":"4193_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_389810","volume":"43","author":"I Mohamad","year":"2023","unstructured":"Mohamad I, Glaun MDE, Prabhash K, Busheri A, Lai SY, Noronha V, et al. Current treatment strategies and risk stratification for oral carcinoma. Am Soc Clin Oncol Educ Book. 2023;43:e389810.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"4","key":"4193_CR5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.oooo.2019.10.012","volume":"129","author":"H Cai","year":"2020","unstructured":"Cai H, Zhu Y, Wang C, Zhang Y, Hou J. Neck nodal recurrence and survival of clinical T1\u20132 N0 oral squamous cell carcinoma in comparison of elective neck dissection versus observation: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;129(4):296\u2013310.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"1","key":"4193_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1097\/JS9.0000000000001953","volume":"111","author":"YF Yu","year":"2025","unstructured":"Yu YF, Cao LM, Li ZZ, Zhong NN, Wang GR, Xiao Y, et al. Frequency of lymph node metastases at different neck levels in patients with oral squamous cell carcinoma: a systematic review and meta-analysis. Int J Surg. 2025;111(1):1285\u2013300.","journal-title":"Int J Surg"},{"issue":"5","key":"4193_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1470-2045(21)00076-0","volume":"22","author":"C Petit","year":"2021","unstructured":"Petit C, Lacas B, Pignon JP, Le QT, Gr\u00e9goire V, Grau C, et al. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. Lancet Oncol. 2021;22(5):727\u201336.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4193_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1080\/13696998.2022.2095826","volume":"25","author":"RH Borse","year":"2022","unstructured":"Borse RH, Ramakrishnan K, Gandhi J, Dhankhar P, Chirovsky D. Cost-effectiveness of pembrolizumab for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in the United States. J Med Econ. 2022;25(1):954\u201365.","journal-title":"J Med Econ"},{"issue":"3","key":"4193_CR9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.21873\/invivo.13205","volume":"37","author":"M Yamauchi","year":"2023","unstructured":"Yamauchi M, Minesaki A, Ishida T, Sato Y, Okamura S, Shuto H, et al. Induction chemotherapy with 5-fluorouracil, cisplatin, and cetuximab in advanced head and neck squamous cell carcinoma. In Vivo. 2023;37(3):1275\u201380.","journal-title":"In Vivo"},{"issue":"5","key":"4193_CR10","volume":"6","author":"C Le Tourneau","year":"2023","unstructured":"Le Tourneau C, Ghiani M, Cau MC, Depenni R, Ronzino G, Bonomo P, et al. First-line cetuximab\u2009+\u2009platinum-based therapy for recurrent\/metastatic head and neck squamous cell carcinoma: a real-world observational study-ENCORE. Cancer Rep. 2023;6(5):e1804.","journal-title":"Cancer Rep"},{"issue":"10","key":"4193_CR11","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/annonc\/mdq077","volume":"21","author":"R Mes\u00eda","year":"2010","unstructured":"Mes\u00eda R, Rivera F, Kawecki A, Rottey S, Hitt R, Kienzer H, et al. Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and\/or metastatic squamous cell carcinoma of the head and neck. Ann Oncol. 2010;21(10):1967\u201373.","journal-title":"Ann Oncol"},{"issue":"1","key":"4193_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02804-z","volume":"42","author":"Y Ma","year":"2023","unstructured":"Ma Y, Guo C, Wang X, Wei X, Ma J. Impact of chemotherapeutic agents on liver microenvironment: oxaliplatin create a pro-metastatic landscape. J Exp Clin Cancer Res. 2023;42(1):237.","journal-title":"J Exp Clin Cancer Res"},{"key":"4193_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-019-0164-y","volume":"24","author":"L Zhu","year":"2019","unstructured":"Zhu L, Chen L. Progress in research on paclitaxel and tumor immunotherapy. Cell Mol Biol Lett. 2019;24:40.","journal-title":"Cell Mol Biol Lett"},{"key":"4193_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jconrel.2021.12.002","volume":"341","author":"X Qiu","year":"2022","unstructured":"Qiu X, Qu Y, Guo B, Zheng H, Meng F, Zhong Z. Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer. J Control Release. 2022;341:498\u2013510.","journal-title":"J Control Release"},{"issue":"3","key":"4193_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1210","volume":"13","author":"SY Hu","year":"2023","unstructured":"Hu SY, Qian JX, Yang SY, Andriani L, Liao L, Deng L, et al. Destabilization of microrchidia family CW-type zinc finger 2 via the cyclin-dependent kinase 1-chaperone-mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule-targeting agents. Clin Transl Med. 2023;13(3):e1210.","journal-title":"Clin Transl Med"},{"key":"4193_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/15347354221134921","volume":"21","author":"PY Hsu","year":"2022","unstructured":"Hsu PY, Chen JL, Kuo SL, Wang WL, Jan FW, Yang SH, et al. San-Zhong-Kui-Jian-Tang exerts antitumor effects associated with decreased cell proliferation and metastasis by targeting ERK and the epithelial-mesenchymal transition pathway in oral cavity squamous cell carcinoma. Integr Cancer Ther. 2022;21:15347354221134921.","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"4193_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04351-y","volume":"7","author":"Z Shi","year":"2017","unstructured":"Shi Z, Song T, Wan Y, Xie J, Yan Y, Shi K, et al. A systematic review and meta-analysis of traditional insect Chinese medicines combined chemotherapy for non-surgical hepatocellular carcinoma therapy. Sci Rep. 2017;7(1):4355.","journal-title":"Sci Rep"},{"issue":"6","key":"4193_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11912-023-01408-2","volume":"25","author":"S Narayanan","year":"2023","unstructured":"Narayanan S, de Mores AR, Cohen L, Anwar MM, Lazar F, Hicklen R, et al. Medicinal mushroom supplements in cancer: a systematic review of clinical studies. Curr Oncol Rep. 2023;25(6):569\u201387.","journal-title":"Curr Oncol Rep"},{"key":"4193_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/15347354231226256","volume":"23","author":"SD Kim","year":"2024","unstructured":"Kim SD, Kim JH, Kim DH, Park JH, Gong Y, Sun C, et al. Comprehensive evaluation of traditional herbal medicine combined with adjuvant chemotherapy on post-surgical gastric cancer: a systematic review and meta-analysis. Integr Cancer Ther. 2024;23:15347354231226256.","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"4193_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02500-w","volume":"22","author":"X Chen","year":"2024","unstructured":"Chen X, He L, Zhang C, Zheng G, Lin S, Zou Y, et al. Exploring new avenues of health protection: plant-derived nanovesicles reshape microbial communities. J Nanobiotechnology. 2024;22(1):269.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"4193_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02193-7","volume":"21","author":"X Chen","year":"2023","unstructured":"Chen X, Xing X, Lin S, Huang L, He L, Zou Y, et al. Plant-derived nanovesicles: harnessing nature\u2019s power for tissue protection and repair. J Nanobiotechnology. 2023;21(1):445.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"4193_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.apsb.2023.08.033","volume":"14","author":"H Liu","year":"2024","unstructured":"Liu H, Luo GF, Shang Z. Plant-derived nanovesicles as an emerging platform for cancer therapy. Acta Pharm Sin B. 2024;14(1):133\u201354.","journal-title":"Acta Pharm Sin B"},{"key":"4193_CR23","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.2147\/IJN.S413831","volume":"18","author":"X Chen","year":"2023","unstructured":"Chen X, Ji S, Yan Y, Lin S, He L, Huang X, et al. Engineered plant-derived nanovesicles facilitate tumor therapy: natural bioactivity plus drug controlled release platform. Int J Nanomedicine. 2023;18:4779\u2013804.","journal-title":"Int J Nanomedicine"},{"key":"4193_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jconrel.2024.01.060","volume":"367","author":"G Yan","year":"2024","unstructured":"Yan G, Xiao Q, Zhao J, Chen H, Xu Y, Tan M, et al. Brucea javanica derived exosome-like nanovesicles deliver miRNAs for cancer therapy. J Control Release. 2024;367:425\u201340.","journal-title":"J Control Release"},{"key":"4193_CR25","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.2147\/IJN.S510339","volume":"20","author":"X Ma","year":"2025","unstructured":"Ma X, Chen N, Zeng P, He Y, Zhang T, Lu Y, et al. Hypericum Perforatum-derived exosomes-like nanovesicles: a novel natural photosensitizer for effective tumor photodynamic therapy. Int J Nanomedicine. 2025;20:1529\u201341.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"4193_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00995-1","volume":"19","author":"M Yang","year":"2021","unstructured":"Yang M, Luo Q, Chen X, Chen F. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma. J Nanobiotechnology. 2021;19(1):259.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"4193_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s40425-019-0817-4","volume":"7","author":"M Cao","year":"2019","unstructured":"Cao M, Yan H, Han X, Weng L, Wei Q, Sun X, et al. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. J Immunother Cancer. 2019;7(1):326.","journal-title":"J Immunother Cancer"},{"key":"4193_CR28","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.2147\/IJN.S362244","volume":"17","author":"T Chen","year":"2022","unstructured":"Chen T, Ma B, Lu S, Zeng L, Wang H, Shi W, et al. Cucumber-derived nanovesicles containing cucurbitacin B for non-small cell lung cancer therapy. Int J Nanomedicine. 2022;17:3583\u201399.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"4193_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12951-023-01835-0","volume":"21","author":"J Liu","year":"2023","unstructured":"Liu J, Xiang J, Jin C, Ye L, Wang L, Gao Y, et al. Medicinal plant-derived mtDNA via nanovesicles induces the cGAS-STING pathway to remold tumor-associated macrophages for tumor regression. J Nanobiotechnology. 2023;21(1):78.","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"4193_CR30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.apsb.2021.08.016","volume":"12","author":"Q Chen","year":"2022","unstructured":"Chen Q, Li Q, Liang Y, Zu M, Chen N, Canup BSB, et al. Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharm Sin B. 2022;12(2):907\u201323.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"4193_CR31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/15384101.2017.1395534","volume":"17","author":"RH Gan","year":"2018","unstructured":"Gan RH, Wei H, Xie J, Zheng DP, Luo EL, Huang XY, et al. Notch1 regulates tongue cancer cells proliferation, apoptosis and invasion. Cell Cycle. 2018;17(2):216\u201324.","journal-title":"Cell Cycle"},{"key":"4193_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154319","volume":"104","author":"F Huang","year":"2022","unstructured":"Huang F, Pang J, Xu L, Niu W, Zhang Y, Li S, et al. Hedyotis diffusa injection induces ferroptosis via the Bax\/Bcl2\/VDAC2\/3 axis in lung adenocarcinoma. Phytomedicine. 2022;104:154319.","journal-title":"Phytomedicine"},{"issue":"Pt A","key":"4193_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116886","volume":"318","author":"J Luo","year":"2024","unstructured":"Luo J, Chen QX, Li P, Yu H, Yu L, Lu JL, et al. Lobelia chinensis Lour inhibits the progression of hepatocellular carcinoma via the regulation of the PTEN\/AKT signaling pathway in vivo and in vitro. J Ethnopharmacol. 2024;318(Pt A):116886.","journal-title":"J Ethnopharmacol"},{"key":"4193_CR34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jep.2017.05.032","volume":"206","author":"L Zhang","year":"2017","unstructured":"Zhang L, Ren B, Zhang J, Liu L, Liu J, Jiang G, et al. Anti-tumor effect of Scutellaria barbata D. Don extracts on ovarian cancer and its phytochemicals characterisation. J Ethnopharmacol. 2017;206:184\u201392.","journal-title":"J Ethnopharmacol"},{"key":"4193_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.113907","volume":"271","author":"H Liu","year":"2021","unstructured":"Liu H, Li X, Duan Y, Xie JB, Piao XL. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K\/AKT\/mTOR pathway. J Ethnopharmacol. 2021;271:113907.","journal-title":"J Ethnopharmacol"},{"key":"4193_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116353","volume":"173","author":"J Xu","year":"2024","unstructured":"Xu J, Zhang Z, Hu H, Yang Y, Xiao C, Xi L, et al. Synergistic antitumor effects of Peiminine and Doxorubicin on breast cancer through enhancing DNA damage via ZEB1. Biomed Pharmacother. 2024;173:116353.","journal-title":"Biomed Pharmacother"},{"key":"4193_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154787","volume":"114","author":"L Xia","year":"2023","unstructured":"Xia L, Liu X, Mao W, Guo Y, Huang J, Hu Y, et al. Panax notoginseng saponins normalises tumour blood vessels by inhibiting EphA2 gene expression to modulate the tumour microenvironment of breast cancer. Phytomedicine. 2023;114:154787.","journal-title":"Phytomedicine"},{"key":"4193_CR38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.ijbiomac.2022.02.112","volume":"206","author":"MK Lu","year":"2022","unstructured":"Lu MK, Chang CC, Chao CH, Hsu YC. Structural changes, and anti-inflammatory, anti-cancer potential of polysaccharides from multiple processing of Rehmannia glutinosa. Int J Biol Macromol. 2022;206:621\u201332.","journal-title":"Int J Biol Macromol"},{"key":"4193_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118024","volume":"328","author":"R Liu","year":"2024","unstructured":"Liu R, Zhang X, Cai Y, Xu S, Xu Q, Ling C, et al. Research progress on medicinal components and pharmacological activities of polygonatum sibiricum. J Ethnopharmacol. 2024;328:118024.","journal-title":"J Ethnopharmacol"},{"issue":"15","key":"4193_CR40","doi-asserted-by":"publisher","first-page":"5809","DOI":"10.7150\/ijbs.77734","volume":"18","author":"XJ Mi","year":"2022","unstructured":"Mi XJ, Park HR, Dhandapani S, Lee S, Kim YJ. Biologically synthesis of gold nanoparticles using Cirsium japonicum var. maackii extract and the study of anti-cancer properties on AGS gastric cancer cells. Int J Biol Sci. 2022;18(15):5809\u201326.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"4193_CR41","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1039\/D2FO02284B","volume":"14","author":"L Baohong","year":"2023","unstructured":"Baohong L, Zhongyuan L, Ying T, Beibei Y, Wenting N, Yiming Y, et al. Latex derived from Ficus carica L. inhibited the growth of NSCLC by regulating the caspase\/gasdermin\/AKT signaling pathway. Food Funct. 2023;14(4):2239\u201348.","journal-title":"Food Funct"},{"issue":"1","key":"4193_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56344-5","volume":"16","author":"B Huang","year":"2025","unstructured":"Huang B, Wang H, Liu S, Hao M, Luo D, Zhou Y, et al. Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis. Nat Commun. 2025;16(1):867.","journal-title":"Nat Commun"},{"key":"4193_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105420","volume":"109","author":"YR Zhou","year":"2024","unstructured":"Zhou YR, Dang JJ, Yang QC, Sun ZJ. The regulation of pyroptosis by post-translational modifications: molecular mechanisms and therapeutic targets. EBioMedicine. 2024;109:105420.","journal-title":"EBioMedicine"},{"issue":"24","key":"4193_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101840","volume":"8","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Zhang T, Ma X, Yang QC, Yang LL, Yang SC, et al. Microenvironment-responsive prodrug-induced pyroptosis boosts cancer immunotherapy. Adv Sci Weinh. 2021;8(24):e2101840.","journal-title":"Adv Sci Weinh"},{"issue":"7","key":"4193_CR45","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1016\/j.apsb.2022.02.024","volume":"12","author":"Q Yang","year":"2022","unstructured":"Yang Q, Ma X, Xiao Y, Zhang T, Yang L, Yang S, et al. Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K\/mTOR and CDK inhibitors to enhance antitumor immunity. Acta Pharm Sin B. 2022;12(7):3139\u201355.","journal-title":"Acta Pharm Sin B"},{"issue":"10","key":"4193_CR46","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.7150\/thno.54072","volume":"11","author":"C Zhan","year":"2021","unstructured":"Zhan C, Huang M, Yang X, Hou J. MLKL: functions beyond serving as the executioner of necroptosis. Theranostics. 2021;11(10):4759\u201369.","journal-title":"Theranostics"},{"key":"4193_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.02.013","author":"W Yang","year":"2025","unstructured":"Yang W, Xu Y, Liu S, Gao L, Li S, Xie X, et al. Mebendazole induces ZBP-1 mediated PANoptosis of acute myeloid leukemia cells by targeting TUBA1A and exerts antileukemia effect. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.02.013.","journal-title":"J Adv Res"},{"key":"4193_CR48","doi-asserted-by":"publisher","DOI":"10.1172\/JCI178303","author":"H Wang","year":"2024","unstructured":"Wang H, Guo S, Gao H, Ding J, Li H, Kong X, et al. Myostatin regulates energy homeostasis through autocrine- and paracrine-mediated microenvironment communication. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI178303.","journal-title":"J Clin Invest"},{"issue":"14","key":"4193_CR49","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.7150\/thno.111635","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chai C, Lin W, Cao J, Li Z, Jin Y, et al. Oxidative stress-mediated PANoptosis and ferroptosis: exploration of multimodal cell death triggered by an AIE-active nano-photosensitizer via photodynamic therapy. Theranostics. 2025;15(14):6665\u201385.","journal-title":"Theranostics"},{"key":"4193_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105582","volume":"168","author":"PMP Ferreira","year":"2021","unstructured":"Ferreira PMP, Sousa RWR, Ferreira JRO, Milit\u00e3o GCG, Bezerra DP. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms. Pharmacol Res. 2021;168:105582.","journal-title":"Pharmacol Res"},{"issue":"1","key":"4193_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1158\/1541-7786.MCR-20-0595","volume":"19","author":"JA Smart","year":"2021","unstructured":"Smart JA, Oleksak JE, Hartsough EJ. Cell adhesion molecules in plasticity and metastasis. Mol Cancer Res. 2021;19(1):25\u201337.","journal-title":"Mol Cancer Res"},{"key":"4193_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101430","author":"N Thapa","year":"2023","unstructured":"Thapa N, Wen T, Cryns VL, Anderson RA. Regulation of cell adhesion and migration via microtubule cytoskeleton organization, cell polarity, and phosphoinositide signaling. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13101430.","journal-title":"Biomolecules"},{"issue":"6","key":"4193_CR53","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41374-022-00739-1","volume":"102","author":"H Kim","year":"2022","unstructured":"Kim H, Lee SB, Myung JK, Park JH, Park E, Kim DI, et al. SLUG is a key regulator of epithelial-mesenchymal transition in pleomorphic adenoma. Lab Invest. 2022;102(6):631\u201340.","journal-title":"Lab Invest"},{"issue":"9","key":"4193_CR54","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2174\/15680096113136660102","volume":"13","author":"Y Wang","year":"2013","unstructured":"Wang Y, Shi J, Chai K, Ying X, Zhou BP. The role of Snail in EMT and tumorigenesis. Curr Cancer Drug Targets. 2013;13(9):963\u201372.","journal-title":"Curr Cancer Drug Targets"},{"issue":"8","key":"4193_CR55","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.addr.2010.11.001","volume":"63","author":"X Zhao","year":"2011","unstructured":"Zhao X, Guan JL. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev. 2011;63(8):610\u20135.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"4193_CR56","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41568-021-00340-6","volume":"21","author":"JC Dawson","year":"2021","unstructured":"Dawson JC, Serrels A, Stupack DG, Schlaepfer DD, Frame MC. Targeting FAK in anticancer combination therapies. Nat Rev Cancer. 2021;21(5):313\u201324.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"4193_CR57","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.devcel.2006.09.009","volume":"11","author":"WP Kloosterman","year":"2006","unstructured":"Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11(4):441\u201350.","journal-title":"Dev Cell"},{"issue":"4","key":"4193_CR58","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41556-022-00880-5","volume":"24","author":"J Shi","year":"2022","unstructured":"Shi J, Zhou T, Chen Q. Exploring the expanding universe of small RNAs. Nat Cell Biol. 2022;24(4):415\u201323.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"4193_CR59","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.fmre.2023.09.007","volume":"5","author":"R Wang","year":"2025","unstructured":"Wang R, Zhang Y, Guo Y, Zeng W, Li J, Wu J, et al. Plant-derived nanovesicles: promising therapeutics and drug delivery nanoplatforms for brain disorders. Fundam Res. 2025;5(2):830\u201350.","journal-title":"Fundam Res"},{"issue":"14","key":"4193_CR60","doi-asserted-by":"publisher","first-page":"7641","DOI":"10.1039\/D4FO01366B","volume":"15","author":"M Kang","year":"2024","unstructured":"Kang M, Kang M, Lee J, Yoo J, Lee S, Oh S. Allium tuberosum-derived nanovesicles with anti-inflammatory properties prevent DSS-induced colitis and modify the gut microbiome. Food Funct. 2024;15(14):7641\u201357.","journal-title":"Food Funct"},{"key":"4193_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114774","volume":"196","author":"G Niu","year":"2023","unstructured":"Niu G, Jian T, Gai Y, Chen J. Microbiota and plant-derived vesicles that serve as therapeutic agents and delivery carriers to regulate metabolic syndrome. Adv Drug Deliv Rev. 2023;196:114774.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4193_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7(1):286.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"4193_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70024","volume":"5","author":"S Qian","year":"2024","unstructured":"Qian S, Long Y, Tan G, Li X, Xiang B, Tao Y, et al. Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets. MedComm. 2024;5(12):e70024.","journal-title":"MedComm"},{"issue":"4","key":"4193_CR64","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1158\/2159-8290.CD-20-1638","volume":"11","author":"M Aldea","year":"2021","unstructured":"Aldea M, Andre F, Marabelle A, Dogan S, Barlesi F, Soria JC. Overcoming resistance to tumor-targeted and immune-targeted therapies. Cancer Discov. 2021;11(4):874\u201399.","journal-title":"Cancer Discov"},{"key":"4193_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102340","volume":"104","author":"S Crucitta","year":"2022","unstructured":"Crucitta S, Cucchiara F, Mathijssen R, Mateo J, Jager A, Joosse A, et al. Treatment-driven tumour heterogeneity and drug resistance: lessons from solid tumours. Cancer Treat Rev. 2022;104:102340.","journal-title":"Cancer Treat Rev"},{"key":"4193_CR66","first-page":"283","volume":"47","author":"QC Yang","year":"2025","unstructured":"Yang QC, Wang YY, Wang S, Song A, Wang WD, Zhang L, et al. Engineered bacterial membrane biomimetic covalent organic framework as nano-immunopotentiator for cancer immunotherapy. Bioact Mater. 2025;47:283\u201394.","journal-title":"Bioact Mater"},{"key":"4193_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106907","volume":"209","author":"K Hou","year":"2025","unstructured":"Hou K, Pan W, Liu L, Yu Q, Ou J, Li Y, et al. Molecular mechanism of PANoptosis and programmed cell death in neurological diseases. Neurobiol Dis. 2025;209:106907.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"4193_CR68","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18(5):1106\u201321.","journal-title":"Cell Mol Immunol"},{"issue":"7876","key":"4193_CR69","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","volume":"597","author":"S Lee","year":"2021","unstructured":"Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti TD. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature. 2021;597(7876):415\u20139.","journal-title":"Nature"},{"issue":"1","key":"4193_CR70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M Rojo de la Vega","year":"2018","unstructured":"Rojo de la Vega M, Chapman E, Zhang DD. NRF2 and the hallmarks of cancer. Cancer Cell. 2018;34(1):21\u201343.","journal-title":"Cancer Cell"},{"issue":"1","key":"4193_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00740-w","volume":"19","author":"S Kim","year":"2024","unstructured":"Kim S, Chun H, Kim Y, Kim Y, Park U, Chu J, et al. Astrocytic autophagy plasticity modulates A\u03b2 clearance and cognitive function in Alzheimer\u2019s disease. Mol Neurodegener. 2024;19(1):55.","journal-title":"Mol Neurodegener"},{"key":"4193_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103066","volume":"70","author":"H Zhang","year":"2024","unstructured":"Zhang H, Pan J, Huang S, Chen X, Chang ACY, Wang C, et al. Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11\/GSH\/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation. Redox Biol. 2024;70:103066.","journal-title":"Redox Biol"},{"key":"4193_CR73","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol. 2018;13:395\u2013412.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"4193_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02338-2","volume":"24","author":"H Allgayer","year":"2025","unstructured":"Allgayer H, Mahapatra S, Mishra B, Swain B, Saha S, Khanra S, et al. Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025. Mol Cancer. 2025;24(1):167.","journal-title":"Mol Cancer"},{"issue":"1","key":"4193_CR75","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm1549","volume":"6","author":"SK Mitra","year":"2005","unstructured":"Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005;6(1):56\u201368.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4193_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104536","volume":"204","author":"ZZ Li","year":"2024","unstructured":"Li ZZ, Zhou K, Wu Q, Liu B, Bu LL. Lymph node metastasis in cancer: clearing the clouds to see the dawn. Crit Rev Oncol Hematol. 2024;204:104536.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"4193_CR77","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.oooo.2020.10.026","volume":"131","author":"S Huang","year":"2021","unstructured":"Huang S, Zhu Y, Cai H, Zhang Y, Hou J. Impact of lymphovascular invasion in oral squamous cell carcinoma: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131(3):319-328.e1.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4193_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113917","volume":"146","author":"LY Wei","year":"2025","unstructured":"Wei LY, Li ZZ, Xu ZY, Wang GR, Xiao Y, Liu B, et al. The ending is not the end: lymph node metastasis in oral squamous cell carcinoma. Int Immunopharmacol. 2025;146:113917.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4193_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduction and Targeted Therapy. 2020;5(1):28.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"2","key":"4193_CR80","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275\u201392.","journal-title":"Cell"},{"key":"4193_CR81","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u20137.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"4193_CR82","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cell.2020.09.064","volume":"183","author":"IH Guldner","year":"2020","unstructured":"Guldner IH, Wang Q, Yang L, Golomb SM, Zhao Z, Lopez JA, et al. CNS-native myeloid cells drive immune suppression in the brain metastatic niche through Cxcl10. Cell. 2020;183(5):1234-1248.e25.","journal-title":"Cell"},{"issue":"5","key":"4193_CR83","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/j.apsb.2024.02.005","volume":"14","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Feng J, Liu F, Liang Q, Xie M, Dong J, et al. Rhizoma drynariae-derived nanovesicles reverse osteoporosis by potentiating osteogenic differentiation of human bone marrow mesenchymal stem cells via targeting ER\u03b1 signaling. Acta Pharm Sin B. 2024;14(5):2210\u201327.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"4193_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct Target Ther. 2024;9(1):176.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4193_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther. 2023;8(1):455.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"4193_CR86","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1016\/j.apsb.2022.08.013","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Li C, Wang Y, Chen H, Zhang X, Luo C, et al. Smart drug delivery systems for precise cancer therapy. Acta Pharm Sin B. 2022;12(11):4098\u2013121.","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"4193_CR87","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/ptr.6167","volume":"32","author":"S Zhang","year":"2018","unstructured":"Zhang S, Chen C, Lu W, Wei L. Phytochemistry, pharmacology, and clinical use of Panax notoginseng flowers buds. Phytother Res. 2018;32(11):2155\u201363.","journal-title":"Phytother Res"},{"issue":"8","key":"4193_CR88","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1016\/j.apsb.2022.12.022","volume":"13","author":"A Li","year":"2023","unstructured":"Li A, Li D, Gu Y, Liu R, Tang X, Zhao Y, et al. Plant-derived nanovesicles: further exploration of biomedical function and application potential. Acta Pharm Sin B. 2023;13(8):3300\u201320.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"4193_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00556-3","volume":"8","author":"S Corvigno","year":"2024","unstructured":"Corvigno S, Liu Y, Bayraktar E, Stur E, Bayram NN, Ahumada AL, et al. Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy. NPJ Precis Oncol. 2024;8(1):86.","journal-title":"NPJ Precis Oncol"},{"issue":"4","key":"4193_CR90","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1142\/S0192415X21500440","volume":"49","author":"H Luo","year":"2021","unstructured":"Luo H, Vong CT, Tan D, Zhang J, Yu H, Yang L, et al. Panax notoginseng saponins modulate the inflammatory response and improve IBD-like symptoms via TLR\/NF-[Formula: see text]B and MAPK signaling pathways. Am J Chin Med. 2021;49(4):925\u201339.","journal-title":"Am J Chin Med"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04193-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04193-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04193-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:04:12Z","timestamp":1776168252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04193-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4193"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04193-9","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal studies were approved by the ethics committee, Fujian Medical University under document number IACUC FJMU 2023\u20130238.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and agreed to submit the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"348"}}